The product was promoted with the false claim that it could "cure 650 diseases", resulting in the prosecution and fining of the companies' owners.
In 2003 US$5.6 million worth of product was seized by the FDA and in the following year the company owners were issued with an order banning them for falsely promoting the Seasilver product, and fining them US$120 million, suspended to US$3 million if the fine was paid promptly. Following non-payment and a failed appeal, the full fine of US$120 million was re-affirmed by a ruling in 2008.
The Seasilver product includes a variety of ingredients including pau d'arco, cranberry and aloe. According to the Memorial Sloan-Kettering Cancer Center, "no studies have shown the efficacy of this costly product", and Quackwatch say there is "no logical reason to use the product".
- "Seasilver". Memorial Sloan-Kettering Cancer Center. 29 September 2012. Retrieved August 2013. Check date values in:
- "Inspections, Compliance, Enforcement, and Criminal Investigations – Warning Letter". Food and Drug Administration. 3 April 2002. Retrieved August 2013. Check date values in:
- "Court orders Seasilver defendants to pay $120 million". Nutraceuticals World. 11 (6): 14. 2008.
- Stephen Barrett, M.D. (August 2004). "Misleading Claims for Seasilver™". Quackwatch. Retrieved August 2013. Check date values in:
- Federal Trade Commission v. Seasilver USA, Inc. – details of FTC action